Panel recommends approval of new cholesterol drug

A Food and Drug Administration advisory committee on Tuesday recommended approval of a new type of experimental cholesterol-fighting drug that could be more potent and carry fewer side effects than statins, which are among the most prescribed drugs in the United States.